Idiopathic Pulmonary Fibrosis | New England Journal of Medicine Skip to main content The
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease characterized by
progressive lung scarring and the histological picture of usual interstitial pneumonia (UIP). It …

The clinical expression of idiopathic pulmonary fibrosis (IPF) is directly related to multiple
alterations in lung function. These alterations derive from a complex disease process …

Background In fibrotic interstitial lung diseases, exertional breathlessness is strongly linked
to health-related quality of life (HRQOL). Breathlessness is often associated with oxygen …

Idiopathic pulmonary fibrosis (IPF) is an advancing and fatal lung disease with increasing
incidence and prevalence. Nintedanib and pirfenidone were approved by the FDA for the …

Idiopathic pulmonary fibrosis (IPF) is a progressive devastating lung disease with substantial
morbidity. It is associated with cough, dyspnea and impaired quality of life. If left untreated …

Pulmonary complications in CTD are common and can involve the interstitium, airways,
pleura and pulmonary vasculature. ILD can occur in all CTD (CTD‐ILD), and may vary from …

Background and objective The management of symptoms in patients with advanced chronic
respiratory diseases needs more attention. This review summarizes the latest evidence on …

Idiopathic pulmonary fibrosis is defined as a chronic progressive fibrosing interstitial
pneumonia of unknown etiology. There are intrinsic and extrinsic risk factors that could favor …

Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease with a poor prognosis and
an unknown cause that generally progresses to pulmonary fibrosis and leads to irreversible …